Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 217 of 217 entries
Sorted by: Best Match Show Resources per page
Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model.

Blood cancer journal

Mori F, Ishida T, Ito A, Sato F, Masaki A, Takino H, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H, Iida S.
PMID: 22829969
Blood Cancer J. 2012 Apr;2(4):e67. doi: 10.1038/bcj.2012.12. Epub 2012 Apr 20.

We established a mouse model of microenvironment-dependent human lymphoma, and assessed the therapeutic potential of bevacizumab, an antitumor agent acting on the microenvironment. NOD/Shi-scid, IL-2Rγ(null) (NOG) mice were used as recipients of primary tumor cells from a patient with...

Cite
Mori F, Ishida T, Ito A, et al. Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model. Blood Cancer J. 2012;2(4):e67doi: 10.1038/bcj.2012.12.
Mori, F., Ishida, T., Ito, A., Sato, F., Masaki, A., Takino, H., Ri, M., Kusumoto, S., Komatsu, H., Ueda, R., Inagaki, H., & Iida, S. (2012). Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model. Blood cancer journal, 2(4), e67. https://doi.org/10.1038/bcj.2012.12
Mori, F, et al. "Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model." Blood cancer journal vol. 2,4 (2012): e67. doi: https://doi.org/10.1038/bcj.2012.12
Mori F, Ishida T, Ito A, Sato F, Masaki A, Takino H, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H, Iida S. Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model. Blood Cancer J. 2012 Apr;2(4):e67. doi: 10.1038/bcj.2012.12. Epub 2012 Apr 20. PMID: 22829969; PMCID: PMC3346682.
Copy Download .nbib Format: NLM
Showing 217 to 217 of 217 entries